metastatic renal cell carcinoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

metastatic renal cell carcinoma
Feb 25, 2025, 11:39 | Blog
Applonia Rose: Exciting findings on prognostic scoring in metastatic renal cell carcinoma
Applonia Rose, Managing Editor at Sage Publishing, shared a paper Ria Nagpal and collegues authored…
Feb 5, 2025, 20:37 | Insight
Enrique Grande: Circulating immune biomarkers linked to response in mRCC patients undergoing immunotherapy
Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared a post on LinkedIn…
Jan 18, 2025, 14:31 | Blog
Aruni Ghose: Pleasure Catching Up with Ankit Jain and Exploring OncoFlow’s Future at Apollo Hospitals
Aruni Ghose, Chief Medical Officer at OncoFlow and Internal Medicine Resident at Barts Health NHS…
Jan 2, 2025, 19:20 | Science
Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC - International Urology Cancer Summit
International Urology Cancer Summit shared an article by Arnab Basu on LinkedIn: "Advancing Precision Oncology…
Oct 14, 2024, 12:57 | Blog
Tanja Obradovic: Genenta Science announces opening of the Temferon trial in mRCC
Tanja Obradovic shared a post on LinkedIn: ''Clinical development landscape in metastatic renal cell carcinoma…
Sep 28, 2024, 18:42 | Insight
Aruni Ghose: The Meet-URO Italian Score went International
Aruni Ghose posted on LinkedIn: “The Meet-URO Italian Score went International - 26 European Centres…
Sep 2, 2024, 08:35 | Insight
Shilpa Gupta: Novel approach of intermittent IO in mRCC
Shilpa Gupta shared a post on X by María Natalia Gandur Quiroga about a recent…
Aug 12, 2024, 09:21 | Insight
Giuseppe Banna: RBC-based scores improving prognostic systems in metastatic RCC
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, recently shared a post…
Jul 9, 2024, 07:25 | Insight
Piotr Wysocki: Checkpoint inhibitor and TKI combinations in GU malignancies
Piotr Wysocki recently posted on LinkedIn: "A phase I study (Apolo AB et al. J Clin…
Jul 5, 2024, 15:03 | Drugs
Andrea Apolo: Phase 1 study of Cabozantinib, Nivolumab, and Ipilimumab for genitourinary tumours
Andrea Apolo, Chief of Bladder Cancer Section Genitourinary Malignancies Branch Center for Cancer Research at…
Jul 1, 2024, 17:38 | Blog
Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients
Sara Elena Rebuzzi, Medical Oncologis at The Hospital of San Paolo, made the following post…
Jun 3, 2024, 15:09 | Insight
Avelumab + Axitinib Did Not Improve Overall Survival in Patients with Metastatic Renal Cell Carcinoma: Don't Panic!
"Final overall survival (OS) and progression-free survival (PFS) results for patients with metastatic clear cell…
Apr 23, 2024, 23:49 | Drugs
Yüksel Ürün: Updated 1st-line treatment in mRCC!
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared a post…
Mar 28, 2024, 03:20 | Blog
Roberto Iacovelli: Thrilled to announce that TIDE-A trial is finally out on European Urology
Roberto Iacovelli, Associate Professor of Medical Oncology at Sacro Cuore Catholic University of Rome, shared on…
Oct 25, 2023, 17:52 | Insight
Ilya Tsimafeyeu: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival
Ilya Tsimafeyeu, Director at Bureau of Cancer Re­search Russia, shared on Facebook: "Our study: Patients…
All: 15 Posts: 1 - 100
Special Coverage